Profiling donepezil template into multipotent hybrids with antioxidant properties
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18470%2F18%3A50014446" target="_blank" >RIV/62690094:18470/18:50014446 - isvavai.cz</a>
Alternative codes found
RIV/60162694:G44__/18:43889471 RIV/00023752:_____/18:43919338 RIV/00179906:_____/18:10373702
Result on the web
<a href="https://www.ncbi.nlm.nih.gov/pubmed/29529892" target="_blank" >https://www.ncbi.nlm.nih.gov/pubmed/29529892</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1080/14756366.2018.1443326" target="_blank" >10.1080/14756366.2018.1443326</a>
Alternative languages
Result language
angličtina
Original language name
Profiling donepezil template into multipotent hybrids with antioxidant properties
Original language description
Alzheimer's disease is debilitating neurodegenerative disorder in the elderly. Current therapy relies on administration of acetylcholinesterase inhibitors (AChEIs) -donepezil, rivastigmine, galantamine, and N-methyl-d-aspartate receptor antagonist memantine. However, their therapeutic effect is only short-term and stabilizes cognitive functions for up to 2 years. Given this drawback together with other pathological hallmarks of the disease taken into consideration, novel approaches have recently emerged to better cope with AD onset or its progression. One such strategy implies broadening the biological profile of AChEIs into so-called multi-target directed ligands (MTDLs). In this review article, we made comprehensive literature survey emphasising on donepezil template which was structurally converted into plethora of MTLDs preserving anti-cholinesterase effect and, at the same time, escalating the anti-oxidant potential, which was reported as a crucial role in the pathogenesis of the Alzheimer's disease. [GRAPHICS] .
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30107 - Medicinal chemistry
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of enzyme inhibition and medicinal chemistry
ISSN
1475-6366
e-ISSN
—
Volume of the periodical
33
Issue of the periodical within the volume
1
Country of publishing house
GB - UNITED KINGDOM
Number of pages
24
Pages from-to
583-606
UT code for WoS article
000427559100001
EID of the result in the Scopus database
—